3-deazaneplanocin has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, W; Duan, R; Guo, W | 1 |
| Kim, JH; Shin, YJ | 1 |
1 review(s) available for 3-deazaneplanocin and Neoplasm Metastasis
| Article | Year |
|---|---|
EZH2: a novel target for cancer treatment.
Topics: Adenosine; Antineoplastic Agents; Benzamides; Biphenyl Compounds; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Epigenetic Repression; Histone Code; Histones; Humans; Methylation; Morpholines; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Polycomb Repressive Complex 2; Pyridones; Structure-Activity Relationship; Transcriptional Activation; Tumor Microenvironment | 2020 |
1 other study(ies) available for 3-deazaneplanocin and Neoplasm Metastasis
| Article | Year |
|---|---|
The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
Topics: Adenosine; Blotting, Western; Cell Line, Tumor; Cell Movement; DNA-Binding Proteins; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Polycomb Repressive Complex 2; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Transcription Factors | 2012 |